Fumaric Acid

Fumaric Acid

SCHEMBL5248161

O=C(O)/C=C/C(=O)O.O=C1c2ccccc2CN1CC1CCN(CCOc2cccc(F)c2)CC1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 1/20 0.54
DRD2 known ✓ P14416 5/20 0.46
HTR1A P08908 6/20 0.54
TMEM97 Q5BJF2 2/20 0.54
HTR7 P34969 8/20 0.46
HTR6 P50406 5/20 0.46
KDM1A O60341 1/20 0.45
ACHE P22303 1/20 0.43
PARP1 P09874 1/20 0.41
KDM4E B2RXH2 1/20 0.40
SCN1A P35498 1/20 0.40
SCN5A Q14524 1/20 0.40
SCN9A Q15858 1/20 0.40
SIGMAR1 Q99720 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL5248173 1.00 HTR1A (0.54) HTR1ATMEM97HTR2AHTR7DRD2
SCHEMBL5251606 0.93 HTR1A (0.56) HTR1ATMEM97HTR2AHTR7DRD2
Fumaric Acid SCHEMBL5252036 0.91 TMEM97 (0.53) HTR1ATMEM97HTR2AHTR7ACHE
Fumaric Acid SCHEMBL5252031 0.91 TMEM97 (0.53) HTR1ATMEM97HTR2AHTR7ACHE
Fumaric Acid SCHEMBL5249516 0.90 HTR7 (0.47) HTR1ATMEM97HTR2AHTR7ACHE
Fumaric Acid SCHEMBL5253079 0.90 SCN1A (0.49) HTR1ATMEM97HTR2AHTR7DRD2
Fumaric Acid SCHEMBL5253080 0.90 SCN1A (0.49) HTR1ATMEM97HTR2AHTR7DRD2
Fumaric Acid SCHEMBL5249513 0.90 HTR7 (0.47) HTR1ATMEM97HTR2AHTR7ACHE
Fumaric Acid SCHEMBL5255919 0.86 HRH3 (0.47) HTR1ATMEM97HTR2AHTR7ACHE
Fumaric Acid SCHEMBL5255072 0.86 HRH3 (0.47) HTR1ATMEM97HTR2AHTR7ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1260512-B1 NOVEL CYCLIC AMIDE DERIVATIVES MITSUBISHI PHARMA CORP (JP) 2007-07-04 EP disclosed
US-7166617-B2 Cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2007-01-23 US disclosed
US-20030212094-A1 Novel cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2003-11-13 US disclosed
EP-1260512-A1 NOVEL CYCLIC AMIDE DERIVATIVES Mitsubishi Pharma Corporation (JP) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212094-A1 Novel cyclic amide derivatives SIGMAR1, OPRM1, OPRD1 HTR2A 153/4885DRD2 402/4885HTR1A 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.